Cognitive Dysfunction Common in Chronic Hypoparathyroidism
TOPLINE:Cognitive dysfunction, particularly in "attention and processing speed," is common in chronic hypoparathyroidism (HypoPT).METHODOLOGY:In 30 patients with HypoPT and 30 ...
TOPLINE:Cognitive dysfunction, particularly in "attention and processing speed," is common in chronic hypoparathyroidism (HypoPT).METHODOLOGY:In 30 patients with HypoPT and 30 ...
(Reuters) -Roivant will discontinue the development of its drug for a rare lung disease after it failed to show treatment ...
It is rare that a drug becomes a household name and even rarer for one to become a superstar, but ...
TOPLINE:Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long ...
LUBUMBASHI, Democratic Republic of the Congo (Reuters) - An unknown disease killed 143 people in Democratic Republic of the Congo's ...
Disparities in participation may be preventing women and racial and ethnic minorities from deriving the full cardiovascular benefits of exercise, ...
TOPLINE:Prasugrel is associated with lower rates of mortality, myocardial infarction (MI), and stroke than ticagrelor under conditions of routine care ...
(Reuters) - Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million ...
TOPLINE:Exposure to individual or mixed per- and polyfluoroalkyl substances (PFASs) is associated with changes in peripheral rather than central thyroid ...
The availability of second-generation obesity drugs (glucagon-like peptide 1 analogues) has raised questions about the role of bariatric surgery. During ...
LAS VEGAS — For clinicians who rely on generic tretinoin 0.5% as their go-to treatment for patients with acne, Shanna ...
Artificial intelligence (AI) is already changing healthcare, but data science training for clinicians and medical students is still largely elective. ...
In a new statement, the American Diabetes Association (ADA) has advised against the use of compounded glucagon-like peptide 1 receptor ...
The US Food and Drug Administration (FDA) has approved ustekinumab-kfce (Yesintek) as a biosimilar to ustekinumab (Stelara) for the treatment ...
(Reuters) - The U.S. Food and Drug Administration and the Centers for Disease Control and Prevention are investigating a multistate ...
© 2022 NewsHealth.
© 2022 NewsHealth.